Cyclo Therapeutics Stock Forecast - Accumulation Distribution
| CYTH Stock | USD 0.68 0.05 6.85% |
Cyclo Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Cyclo Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Cyclo |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2619.54 | 3741.26 |
| Check Cyclo Therapeutics Volatility | Backtest Cyclo Therapeutics | Information Ratio |
Cyclo Therapeutics Trading Date Momentum
| On November 26 2024 Cyclo Therapeutics was traded for 0.68 at the closing time. The top price for the day was 0.69 and the lowest listed price was 0.60 . The trading volume for the day was 28.7 K. The trading history from November 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.94% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cyclo Therapeutics to competition |
Other Forecasting Options for Cyclo Therapeutics
For every potential investor in Cyclo, whether a beginner or expert, Cyclo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cyclo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cyclo. Basic forecasting techniques help filter out the noise by identifying Cyclo Therapeutics' price trends.Cyclo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cyclo Therapeutics stock to make a market-neutral strategy. Peer analysis of Cyclo Therapeutics could also be used in its relative valuation, which is a method of valuing Cyclo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cyclo Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cyclo Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cyclo Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cyclo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cyclo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyclo Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyclo Therapeutics stock market strength indicators, traders can identify Cyclo Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 3741.26 | |||
| Daily Balance Of Power | (0.56) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.65 | |||
| Day Typical Price | 0.66 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | (0.05) |
Cyclo Therapeutics Risk Indicators
The analysis of Cyclo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cyclo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cyclo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.39 | |||
| Standard Deviation | 4.39 | |||
| Variance | 19.31 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Cyclo Therapeutics is a strong investment it is important to analyze Cyclo Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cyclo Therapeutics' future performance. For an informed investment choice regarding Cyclo Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Cyclo Therapeutics to cross-verify your projections. For more detail on how to invest in Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclo Therapeutics. If investors know Cyclo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.046 | Quarterly Revenue Growth 0.051 | Return On Assets (2.82) | Return On Equity (226.64) |
The market value of Cyclo Therapeutics is measured differently than its book value, which is the value of Cyclo that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclo Therapeutics' market value can be influenced by many factors that don't directly affect Cyclo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.